ROYAL BANK OF CANADA - HISTOGENICS CORP ownership

HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 29 filers reported holding HISTOGENICS CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of HISTOGENICS CORP
ValueSharesWeighting
Q2 2019$02,508
-1.4%
0.00%
Q1 2019$02,5430.0%0.00%
Q4 2018$0
-100.0%
2,5430.0%0.00%
Q3 2018$1,000
-83.3%
2,543
+1.7%
0.00%
Q2 2018$6,0002,500
+27677.8%
0.00%
Q4 2017$090.0%0.00%
Q3 2017$09
-85.2%
0.00%
Q4 2016$0610.0%0.00%
Q3 2016$0610.0%0.00%
Q2 2016$0610.00%
Other shareholders
HISTOGENICS CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Third Security, LLC 2,690,570$6,161,0000.24%
Palo Alto Investors LP 454,545$1,041,0000.08%
CARL DOMINO INC 20,910$48,0000.04%
SABBY MANAGEMENT, LLC 150,630$345,0000.02%
Mount Lucas Management LP 7,500$17,0000.00%
J.P. Morgan Private Wealth Advisors LLC 48,455$111,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 23,780$54,0000.00%
FMR LLC 1,906,720$4,366,0000.00%
BlackRock Investment Management, LLC 979$2,0000.00%
BlackRock Fund Advisors 15,938$36,0000.00%
View complete list of HISTOGENICS CORP shareholders